Company intelligence / Profile preview
NewcelX
Zurich, Zurich, Switzerland
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
NewcelX is a clinical-stage biopharmaceutical company focused on developing transformative therapies for neurodegenerative and metabolic diseases. Formed by the 2025 merger of NLS Pharmaceutics and Kadimastem, the company combines a proprietary human pluripotent stem cell (hPSC) platform with small-molecule expertise in central nervous system (CNS) disorders. Its lead program, IsletRx (NCEL-101), aims to provide a functional cure for Type 1 Diabetes by delivering off-the-shelf, insulin-producing cells in collaboration with Eledon Pharmaceuticals. NewcelX also advances AstroRx, a cell therapy currently in Phase 2a clinical development for Amyotrophic Lateral Sclerosis (ALS), alongside a suite of small-molecule treatments for conditions like narcolepsy and ADHD. The company is headquartered in Zurich, Switzerland, with specialized R&D facilities in Ness Ziona, Israel.
- Therapeutic areas
- PsychiatryEndocrinologyNeurology
- Modalities
- Cell therapySmall moleculeStem cell therapyInduced pluripotent stem cell derived therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Eledon PharmaceuticalsBIRD Foundation
Beyond the preview
Go deeper on NewcelX.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NewcelX.